Introduction: Intraocular barriers are physiological and anatomical obstacles—such as the tear film, corneal epithelium, conjunctiva, blood-aqueous barrier and blood-retinal barrier—that restrict drug entry and distribution within the eye. Understanding permeability, ocular clearance, efflux transporters, enzymatic metabolism and melanin binding is essential for rational ocular drug design. Methods to overcome these barriers include topical penetration enhancers, prodrugs, nanoparticles, liposomes, in-situ gels, iontophoresis, intravitreal injection and sustained-release implants. This topic links ocular pharmacokinetics, formulation strategies and targeted delivery approaches important for B.Pharm students preparing for clinical and research roles. Now let’s test your knowledge with 30 MCQs on this topic.
Q1. What is the primary function of the corneal epithelium in ocular drug delivery?
- Serve as a hydrophilic pathway for drug diffusion
- Act as a lipophilic barrier limiting permeation of hydrophilic drugs
- Increase tear turnover to enhance drug absorption
- Promote enzymatic activation of prodrugs
Correct Answer: Act as a lipophilic barrier limiting permeation of hydrophilic drugs
Q2. Which barrier principally prevents systemically administered drugs from reaching the neural retina?
- Corneal stroma
- Blood-aqueous barrier
- Blood-retinal barrier
- Tear film
Correct Answer: Blood-retinal barrier
Q3. Which component of the tear film most affects the residence time of topical ophthalmic formulations?
- Lipid layer
- Aqueous layer
- Mucin layer
- Electrolyte composition
Correct Answer: Mucin layer
Q4. P-glycoprotein (P-gp) expressed in ocular tissues primarily contributes to:
- Increased corneal permeability of large molecules
- Active efflux of drugs reducing intracellular drug concentration
- Enzymatic degradation of peptides in tears
- Formation of tight junctions between endothelial cells
Correct Answer: Active efflux of drugs reducing intracellular drug concentration
Q5. Which strategy is most appropriate to enhance corneal penetration of a hydrophilic drug?
- Increase lipophilicity via prodrug formation
- Decrease drug molecular weight by chemical cleavage
- Administer as an aqueous solution without additives
- Increase ionic strength of formulation
Correct Answer: Increase lipophilicity via prodrug formation
Q6. Intravitreal injection bypasses which ocular barriers directly?
- Tear film and corneal epithelium
- Blink reflex only
- Conjunctival blood vessels only
Correct Answer: Tear film and corneal epithelium
Q7. Which delivery system provides sustained intraocular drug release with minimal patient compliance issues?
- Topical eye drops every 2 hours
- Biodegradable intravitreal implant
- Single oral tablet
- Short-acting subconjunctival injection
Correct Answer: Biodegradable intravitreal implant
Q8. Melanin binding in the uveal tract affects drug delivery by:
- Increasing immediate bioavailability in aqueous humor
- Sequestering lipophilic drugs and prolonging ocular retention
- Promoting rapid renal excretion of drugs
- Enhancing corneal epithelial turnover
Correct Answer: Sequestering lipophilic drugs and prolonging ocular retention
Q9. Which route is most effective for targeting the posterior segment while minimizing systemic exposure?
- Topical administration
- Intravitreal administration
- Oral administration
- Inhalational delivery
Correct Answer: Intravitreal administration
Q10. Mucoadhesive polymers in ophthalmic formulations primarily improve drug delivery by:
- Reducing drug solubility
- Prolonging precorneal residence time
- Increasing systemic absorption
- Degrading corneal tight junctions
Correct Answer: Prolonging precorneal residence time
Q11. Which property of nanoparticles most significantly enhances retinal delivery after intravitreal injection?
- Positive surface charge to interact with vitreous components
- Large particle size (>1 μm) to prevent diffusion
- Low drug loading capacity
- Hydrophobic coating that prevents cellular uptake
Correct Answer: Positive surface charge to interact with vitreous components
Q12. Iontophoresis enhances ocular drug delivery by:
- Using ultrasonic waves to disrupt corneal epithelium
- Applying an electric field to drive charged drugs across tissues
- Increasing tear secretion mechanically
- Forming covalent bonds with corneal proteins
Correct Answer: Applying an electric field to drive charged drugs across tissues
Q13. Which enzymatic system in the eye can metabolize ester prodrugs to active drugs?
- Proteases in the lens
- Esterases in corneal epithelium and tear fluid
- Cytochrome P450 in aqueous humor
- Kinases in the vitreous
Correct Answer: Esterases in corneal epithelium and tear fluid
Q14. The main clearance route for topically applied drugs from the precorneal area is:
- Systemic absorption through conjunctival blood vessels and nasolacrimal drainage
- Enzymatic metabolism in the retina
- Direct diffusion to the optic nerve
- Transscleral lymphatic transport exclusively
Correct Answer: Systemic absorption through conjunctival blood vessels and nasolacrimal drainage
Q15. Which characteristic favors scleral permeation of molecules to reach the posterior segment?
- High lipophilicity and large molecular weight
- Small size and hydrophilicity
- Strong positive charge and high affinity to melanin
- Extensive plasma protein binding
Correct Answer: Small size and hydrophilicity
Q16. Liposomes improve ocular delivery mainly by:
- Acting as efflux pump inhibitors in the retina
- Encapsulating drugs to enhance solubility and corneal penetration
- Causing permanent opening of tight junctions
- Neutralizing tear enzymes completely
Correct Answer: Encapsulating drugs to enhance solubility and corneal penetration
Q17. Which of the following is a dynamic barrier affecting ocular drug availability?
- Corneal epithelium tight junctions
- Tear turnover and nasolacrimal drainage
- Blood-retinal tight junctions
- Lens capsule impermeability
Correct Answer: Tear turnover and nasolacrimal drainage
Q18. For delivery to the choroid and retina from a periocular route, which factor is most limiting?
- Conjunctival blood flow and lymphatic clearance
- Accommodative movements of the lens
- Tear film lipid composition
- Presence of corneal nerves
Correct Answer: Conjunctival blood flow and lymphatic clearance
Q19. Which formulation approach reduces dosing frequency by forming a gel upon instillation?
- Isotonic saline solution
- In-situ gelling system
- Simple suspension with no polymers
- Immediate-release ointment
Correct Answer: In-situ gelling system
Q20. Which physicochemical parameter most strongly influences corneal epithelial permeation of drugs?
- pKa and ionization at tear pH
- Color of the drug
- Optical rotation
- Manufacturing date
Correct Answer: pKa and ionization at tear pH
Q21. Subconjunctival injection is used clinically primarily to:
- Deliver drugs to the anterior chamber only
- Provide periocular depot for sustained posterior segment delivery
- Replace intravitreal injections for endophthalmitis routinely
- Enhance systemic bioavailability of ocular drugs
Correct Answer: Provide periocular depot for sustained posterior segment delivery
Q22. Which of the following enhances transcorneal permeation by transiently opening epithelial tight junctions?
- Cyclodextrins at low concentration
- Benzalkonium chloride as a preservative
- Liposomes without surfactant
- Systemic antihistamines
Correct Answer: Benzalkonium chloride as a preservative
Q23. Which ocular tissue expresses the highest metabolic activity affecting peptide drugs?
- Vitreous humor
- Corneal epithelium and tear fluid
- Retinal pigment epithelium exclusively
- Sclera devoid of enzymes
Correct Answer: Corneal epithelium and tear fluid
Q24. Which property of drug molecules favors penetration across the blood-retinal barrier?
- High polarity and large molecular size
- High lipophilicity and low plasma protein binding
- Strong P-gp substrate characteristics
- Extensive ionization at physiological pH
Correct Answer: High lipophilicity and low plasma protein binding
Q25. Cyclodextrins in ophthalmic formulations mainly function to:
- Act as penetration enhancers by disrupting corneal cells
- Form inclusion complexes to improve solubility of lipophilic drugs
- Stimulate tear production
- Bind to melanin and reduce drug action
Correct Answer: Form inclusion complexes to improve solubility of lipophilic drugs
Q26. Which delivery approach minimizes repeat intravitreal injections for chronic retinal diseases?
- Frequent topical NSAID drops
- Biodegradable intravitreal depot implants
- Single oral antibiotic course
- Short-acting subconjunctival injections weekly
Correct Answer: Biodegradable intravitreal depot implants
Q27. Which barrier class includes tear film, corneal epithelium and conjunctival mucus?
- Metabolic barriers
- Static barriers
- Dynamic barriers
- Immunological barriers only
Correct Answer: Static barriers
Q28. What is the main advantage of prodrug design for ocular delivery?
- Make drugs more antigenic
- Improve corneal permeability and then convert to active drug in ocular tissues
- Increase systemic side effects intentionally
- Completely prevent enzymatic hydrolysis
Correct Answer: Improve corneal permeability and then convert to active drug in ocular tissues
Q29. Which statement about topical ocular delivery to posterior segment is correct?
- Topical drops routinely achieve therapeutic retinal concentrations for large molecules
- Topical delivery faces major limitations due to precorneal clearance and tissue barriers
- Topical route bypasses blood-retinal barrier effectively
- Topical delivery is preferred for macromolecular biologics targeting retina
Correct Answer: Topical delivery faces major limitations due to precorneal clearance and tissue barriers
Q30. Which is an important consideration when designing nanoparticles for intravitreal use?
- Particle size, surface charge, biocompatibility and degradation profile
- Ability to cause permanent vitreous liquefaction
- Strong immunogenicity to recruit leukocytes
- Non-biodegradable metals that remain indefinitely
Correct Answer: Particle size, surface charge, biocompatibility and degradation profile
